Clinical Trial Update: A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation [Phase 3]

View source ↗

Summary

A Phase 3, open-label study of Eisai's E7040 in Japanese subjects with hypervascular tumor and arteriovenous malformation has completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformation
• Hypervascular Tumor

Drugs mentioned

• E7040

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Hypervascular Tumor and Arteriovenous Malformation | Phase 3 | Status: COMPLETED | Results posted: 2016-02-22